These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33463731)

  • 1. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
    Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
    Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
    mSphere; 2021 May; 6(3):. PubMed ID: 34011679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy.
    Azzolini C; Donati S; Premi E; Baj A; Siracusa C; Genoni A; Grossi PA; Azzi L; Sessa F; Dentali F; Severgnini P; Minoja G; Cabrini L; Chiaravalli M; Veronesi G; Carcano G; Maffioli LS; Tagliabue A
    JAMA Ophthalmol; 2021 Sep; 139(9):956-963. PubMed ID: 33662099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.
    Rokohl AC; Grajewski RS; Wawer Matos PA; Koch HL; Dewald F; Klein F; Fätkenheuer G; Lehmann C; Cursiefen C; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1605-1608. PubMed ID: 33511435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
    Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
    Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
    JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
    J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.
    Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P
    Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
    Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
    Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the simultaneous conjunctiva and oropharynx-nasopharynx swab results in patients applying to the SARS-CoV-2 outpatient clinic for the first time.
    Gunduz A; Firat M; Turkoglu G
    J Med Virol; 2021 Jul; 93(7):4516-4522. PubMed ID: 33783859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
    Tutuncu EE; Ozgur D; Karamese M
    J Med Virol; 2021 May; 93(5):2932-2937. PubMed ID: 33501645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations.
    Klingen RL; Katschinski B; Anastasiou OE; Ross RS; Dittmer U; Le-Trilling VTK; Trilling M
    J Med Virol; 2021 May; 93(5):2848-2856. PubMed ID: 33289117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.